Status:
TERMINATED
Constructing an Insulin-Like Growth Factor-based Prediction Model
Lead Sponsor:
University of California, Los Angeles
Conditions:
Growth Hormone Deficiency
Idiopathic Short Stature
Eligibility:
All Genders
3-14 years
Brief Summary
Serum insulin-like growth factor-I (IGF-I) measurements have been shown to correlate well with growth hormone action and effect, and recent data show that serum IGF-I may be related to safety and effi...
Detailed Description
The first phase of our study, previously approved by the UCLA IRB in August 2004, involved a retrospective chart review and collection of preexisting data. We analyzed charts of patients who underwent...
Eligibility Criteria
Inclusion
- Prepubertal patients,
- Male/female,
- Ages 3-14 yrs,
- Being treated with growth hormone for the conditions of growth hormone deficiency, idiopathic short stature, and small-for-gestational age with failure to catch up to the normal growth curve by age 2 years.
Exclusion
- Patients being treated with growth hormone for other conditions such as Turner syndrome, chronic renal failure, or Prader-Willi syndrome
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00263445
Start Date
August 1 2004
End Date
July 1 2012
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Pediatric Endocrinology
Los Angeles, California, United States, 90095